Skip to main content

Kiora Pharmaceuticals Inc

KPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001372514

No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.

Other share classesKPHMW

Q2 2026 vs. Q1 2026

How the institutions holding Kiora Pharmaceuticals Inc changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of KPRX: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders1822+4
Shares339.2K1.11M+766.4K (+225.9%)
Value$654.7K$2.91M+$2.25M (+344.1%)

New holders (10)

Institutions that held Kiora Pharmaceuticals Inc at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to KPRX in Q2 2026
InstitutionSharesValue% of portfolio
Perceptive Advisors LLC438,471$1.15M0.02%
Two Sigma Investments, LP88,792$233.5K0.00%
Millennium Management LLC74,202$195.2K0.00%
HRT Financial LP58,612$154.0K0.00%
Renaissance Technologies LLC29,824$78.4K0.00%
Scientech Research LLC18,746$49.3K0.04%
LPL Financial LLC12,500$32.9K0.00%
Dimensional Fund Advisors LP12,138$31.9K0.00%
Northern Trust Corp11,767$30.9K0.00%
Jane Street Group, LLC10,615$27.9K0.00%

Sold out (6)

Institutions that held Kiora Pharmaceuticals Inc at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of KPRX in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
XTX Topco Ltd14,719$28.4K
Two Sigma Securities, LLC12,019$23.2K
Rangeley Capital, LLC10,000$19.3K
Vanguard Global Advisers, LLC200$386
GWM Advisors LLC22$42
Advisor Group Holdings, Inc.2$3